The FDA’s Arthritis Advisory Committee has recommended approval of all indications for Celltrion, Inc.’s proposed biosimilar.
New ADHD drug, Adzenys, addresses unmet need for patients who struggle to swallow tablets, says GlobalData analyst.
Syrspend SF and Syrspend SF Grape suspending agents by Fagron: FDA Alert - microbial contamination with yeast.
Creating a global consensus for antimicrobial breakpoint to combat antibiotic resistance in future drugs.
Contract manufacturing continues to rise within the Indian pharmaceutical industry, paving the way for SMEs to capitalize and grow.
Utilizing intellectual property rights during the creation of new drugs.
Results from a Phase 1b/2 trial suggest that this drug is effective for the treatment of recurrent C. difficile infection.
Immune Pharmaceuticals files new patent application for Ceplene in combination with checkpoint inhibitors.
New anti-radiation product to assist in cancer radiation treatment released and new anti-malaria treatment in production.
Merck’s Zepatier will threaten the dominance of Gilead’s Harvoni in hepatitis C market, says GlobalData analyst.